Infectious Period of Influenza After Symptom Onset

Infectious Period by Age Group

• Adults with influenza are typically contagious from the day before symptoms begin through the fifth to sixth day after symptom onset, while children can be infectious for up to 10 days after symptoms begin, according to the Centers for Disease Control and Prevention 1, 2, 3
• Adults are contagious from 1 day before symptoms through approximately 5-6 days after symptom onset, as recommended by the Morbidity and Mortality Weekly Report 2, 3
• Children can be infectious before symptoms begin and for as many as 10 days after symptom onset, as stated by the American Academy of Pediatrics 1, 4
• Severely immunocompromised persons may shed virus for weeks or months, according to the Morbidity and Mortality Weekly Report 2

Viral Shedding Patterns

• Viral shedding decreases rapidly by 3-5 days after illness onset in most adults, with a moderate level of evidence, as reported by the Morbidity and Mortality Weekly Report 2
• Most adults complete viral shedding by 5-7 days after illness onset, with a high level of evidence, according to the Morbidity and Mortality Weekly Report 2
• Young children can shed virus several days before illness onset, as stated by the Morbidity and Mortality Weekly Report 2
• The amount of virus shed correlates with infectivity and transmission risk, with a strong level of evidence, according to the Morbidity and Mortality Weekly Report 2

Special Populations with Prolonged Infectious Periods

• Immunocompromised patients can shed virus for weeks to months, as reported by the Morbidity and Mortality Weekly Report 2
• Patients with severe disease may experience prolonged viral replication, especially those with comorbidities or receiving corticosteroid therapy, with a moderate level of evidence, according to the Morbidity and Mortality Weekly Report 2
• Patients with chronic cardiopulmonary conditions may experience prolonged symptoms and viral shedding, as stated by the American Academy of Pediatrics 1
• Patients with certain neuromuscular conditions may have extended infectious periods, with a low level of evidence, according to the American Academy of Pediatrics 1

Clinical Course and Infectivity

• Influenza incubation period is 1-4 days, with an average of 2 days, with a high level of evidence, as reported by the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 3
• Uncomplicated influenza typically resolves after 3-7 days for most people, with a moderate level of evidence, according to the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 3
• Cough and malaise can persist for more than 2 weeks even after the infectious period ends, with a low level of evidence, as stated by the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 3
• Fever and respiratory symptoms correlate with highest infectivity, with a strong level of evidence, according to the Centers for Disease Control and Prevention 3

Implications for Isolation and Prevention

• Isolation measures should continue for at least 5-6 days after symptom onset in adults, with a high level of evidence, as recommended by the Morbidity and Mortality Weekly Report and the Centers for Disease Control and Prevention 2, 3
• For children, isolation should be maintained for up to 10 days after symptom onset, with a moderate level of evidence, according to the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 4
• For immunocompromised patients, longer isolation periods may be necessary, with a low level of evidence, as reported by the Morbidity and Mortality Weekly Report 2

Infectious Period for Influenza A

Special Populations with Extended Infectious Periods

• Immunocompromised individuals may shed virus for weeks to months, requiring extended isolation precautions, as recommended by the American Society of Transplantation 5

Transmission Dynamics

• Influenza A is most contagious shortly after symptom onset, with infectivity decreasing steadily over the course of illness, according to the European Centre for Disease Prevention and Control 6, 7
• The virus spreads primarily through large respiratory droplets from coughing and sneezing, as well as direct or indirect contact with contaminated surfaces or hands, as reported by the European Centre for Disease Prevention and Control 6, 7

Clinical Implications for Isolation

• For hospitalized patients, isolation using Standard and Droplet Precautions should be implemented until hospital discharge or until symptoms resolve and the patient has been afebrile for at least 24 hours, as recommended by the American Society of Transplantation 5
• For immunocompromised patients, longer isolation periods may be necessary due to prolonged viral shedding, according to the American Society of Transplantation 5

Duration of Contagiousness for Influenza A

Clinical Implications for Isolation

• Solid organ transplant recipients and other immunosuppressed individuals may be contagious for 10 or more days, requiring extended isolation precautions and documentation of negative testing before discontinuing precautions 8
• The American Society of Transplantation recommends that isolation precautions should continue until hospital discharge or until signs and symptoms resolve and the patient has been afebrile for at least 24 hours 8
• For immunocompromised hospitalized patients, consider maintaining droplet precautions until hospital discharge or documentation of negative H1N1 testing 8

Duration of Influenza Contagiousness After Testing Positive

Special Populations with Prolonged Contagiousness

• Severely immunocompromised individuals may shed virus for weeks to months, requiring extended isolation precautions well beyond the standard timeframes, according to the American Society of Transplantation 9

Clinical Implications for Isolation

• In acute-care facilities, personnel with influenza-like illness should be removed from direct patient contact duties, with more stringent criteria applied for those working in intensive care units, nurseries, and transplant units, as recommended by the Centers for Disease Control and Prevention 10
• For hospitalized patients, isolation using Standard and Droplet Precautions should continue until hospital discharge or until symptoms resolve and the patient has been afebrile for at least 24 hours, according to the American Society of Transplantation 9

Important Caveats

• To reduce transmission of drug-resistant virus, avoid contact between high-risk individuals and patients taking antivirals for treatment during therapy and for 2 days after discontinuation, as recommended by the Centers for Disease Control and Prevention 10, 11
• Early treatment with neuraminidase inhibitors (within 24-48 hours of symptom onset) may reduce duration of viral shedding, though the primary benefit is reducing symptom duration by approximately 24 hours, according to the Infectious Diseases Society of America 12
• For patients with recent flu-like symptoms, the relatively short duration of positive assays (often 5-7 days or less from symptom onset) should be considered when screening, according to the American Society of Transplantation 9

Patients with Severe Disease

• Those with severe influenza, extensive pneumonia, respiratory failure, or acute respiratory distress syndrome may experience prolonged viral replication, according to the Infectious Diseases Society of America 12

Influenza Infectious Period

Infectious Timeline

• Transmission begins 1 day before symptom onset, making pre-symptomatic spread a critical epidemiologic feature that complicates containment efforts in the general population, including adults and children 13, 14
• Some infected individuals remain asymptomatic yet contagious throughout their infection, posing a risk to others 14

Duration by Population

• Children can be infectious before symptoms begin and for up to 10 days after symptom onset, requiring extended isolation precautions 13
• Immunocompromised patients, including solid organ transplant recipients and those with severe immunodeficiency, may shed virus for weeks to months, necessitating prolonged isolation measures 13

Clinical Implications for Isolation

• The American College of Transplantation recommends implementing Standard and Droplet Precautions immediately upon suspicion of influenza in hospital settings, including the use of surgical masks, nonsterile gloves, and gowns by healthcare personnel 13
• Isolation precautions should continue until hospital discharge or until symptoms resolve and the patient has been afebrile for at least 24 hours, with consideration for maintaining precautions until hospital discharge or negative testing for immunocompromised patients 13
• Household contacts who are unimmunized may be candidates for antiviral prophylaxis to prevent transmission 13

Environmental Persistence

• Influenza virus can survive on hard, nonporous surfaces for 24-48 hours, on porous materials like cloth or paper for less than 8-12 hours, and on human hands for up to 3 hours, highlighting the importance of proper hygiene and surface cleaning 13

Infectious Period and Asymptomatic Transmission of Influenza

Children

• Children can be infectious before symptoms begin and remain contagious for up to 10 days after symptom onset; therefore, isolation should be maintained for the full 10‑day period in this population. 15

Asymptomatic Individuals

• Some infected individuals may remain asymptomatic yet contagious throughout their infection, indicating that transmission can occur even in the absence of clinical signs. 15

Duration of Influenza Contagiousness Across Populations

Healthy Adults

• Influenza infection becomes transmissible one day before symptom onset and most adults stop shedding virus by approximately day 5–6 after symptoms begin; therefore, isolation should extend at least through this period. 16
• Pre‑symptomatic transmission (the day before symptoms appear) is a key epidemiologic factor that hampers containment efforts. 16

Children

• Pediatric cases can transmit influenza up to 10 days after symptom onset, with the possibility of pre‑symptomatic shedding, necessitating a longer isolation window than for adults. 16

Immunocompromised Individuals

• Severely immunocompromised patients (e.g., solid‑organ transplant recipients, chemotherapy recipients, persons with advanced HIV) may shed influenza virus for weeks to months, far exceeding the typical adult duration. 16
• Documented cases show viral shedding lasting ≥10 days in this population, supporting the need for extended isolation precautions. 16
• Isolation for immunocompromised patients should be maintained until hospital discharge or until a negative influenza test is documented. 16

Hospital Isolation Precautions

• Standard and droplet precautions (surgical mask, gloves, gown) must be instituted immediately upon suspicion of influenza in any patient. 16
• Patients should be placed in private rooms with doors closed; if unavailable, cohort confirmed cases together. 16
• Precautions remain until discharge, or until the patient is afebrile for ≥24 hours and symptoms have resolved. 16
• For hospitalized immunocompromised patients, droplet precautions continue until discharge or documented negative influenza testing. 16
• Hospital visitors exhibiting respiratory symptoms should be discouraged, and asymptomatic visitors should wear surgical masks and gloves to reduce transmission risk. 16

Common Pitfalls

• Do not assume a patient is non‑contagious solely because fever has resolved; viral shedding can persist for ≥24 hours after fever subsides. 16
• Do not apply adult isolation timelines to children; pediatric patients require up to 10 days of precautions. 16
• Do not underestimate the infectious period in immunocompromised patients; they may need weeks of isolation and a negative test before discontinuing precautions. 16